EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 23 (2016) Parasite, 23 (2016) 3 References
Open Access
Issue
Parasite
Volume 23, 2016
Article Number 3
Number of page(s) 8
DOI https://doi.org/10.1051/parasite/2016003
Published online 02 February 2016
  1. Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR. 2007. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. American Journal of Tropical Medicine and Hygiene, 76, 641–647. [Google Scholar]
  2. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale J-C, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D. 2013. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature, 505, 50–55. [Google Scholar]
  3. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han K-T, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ. 2014. Spread of artemisinin resistance in Plasmodium falciparum Malaria. New England Journal of Medicine, 371, 411–423. [Google Scholar]
  4. Babiker HA, Schneider P, Reece SE. 2008. Gametocytes: insights gained during a decade of molecular monitoring. Trends in Parasitology, 24, 525–530. [CrossRef] [PubMed] [Google Scholar]
  5. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL. 2005. Effect of Artemether-Lumefantrine policy and improved vector control on malaria burden in KwaZulu–Natal, South Africa. PLoS Medicine, 2, e330–12. [CrossRef] [PubMed] [Google Scholar]
  6. Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ. 2008. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. Journal of Infectious Diseases, 197, 1605–1613. [CrossRef] [Google Scholar]
  7. Bousema T, Drakeley C. 2011. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clinical Microbiology Reviews, 24, 377–410. [CrossRef] [PubMed] [Google Scholar]
  8. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C. 2010. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malaria Journal, 9, 136. [CrossRef] [PubMed] [Google Scholar]
  9. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F. 2009. Changes in the treatment responses to artesunate-mefloquine on the Northwestern border of Thailand during 13 years of continuous deployment. PLoS One, 4, e4551. [CrossRef] [PubMed] [Google Scholar]
  10. Chen PQ, Li GQ, Guo XB. 1994. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinine. Zhonghua Yi Xue Za Zhi, 74, 209(10), 253–254. [Google Scholar]
  11. Chevalley S, Coste A, Lopez A, Pipy B, Valentin A. 2010. Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malaria Journal, 9, 49. [CrossRef] [PubMed] [Google Scholar]
  12. de Vries PJ, Dien TK. 1996. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs, 52, 818–836. [CrossRef] [PubMed] [Google Scholar]
  13. Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV. 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene, 69, 558–563. [Google Scholar]
  14. Djimdé AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK. 2008. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. American Journal of Tropical Medicine and Hygiene, 78, 455–461. [Google Scholar]
  15. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GAT. 2006. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends in Parasitology, 22, 424–430. [CrossRef] [PubMed] [Google Scholar]
  16. Dutta GP, Bajpai R, Vishwakarma RA. 1989. Artemisinin (qinghaosu) – a new gametocytocidal drug for malaria. Chemotherapy, 35, 200–207. [CrossRef] [PubMed] [Google Scholar]
  17. Dutta GP, Mohan A, Tripathi R. 2015. Study of gametocytocidal action of artemisinin by EM. Journal of Parasitology, 76, 1–5. [CrossRef] [Google Scholar]
  18. Giao PT, Binh TQ, Kager PA, Long HP, Van Thang N, Van Nam N, de Vries PJ. 2001. Artemisinin for treatment of uncomplicated falciparum malaria: Is there a place for monotherapy? American Journal of Tropical Medicine and Hygiene, 65, 690–695. [Google Scholar]
  19. Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, Mumba D, Kekre M, Yavo W, Mead D, Bouyou-Akotet M, Apinjoh T, Golassa L, Randrianarivelojosia M, Andagalu B, Maiga-Ascofare O, Amambua-Ngwa A, Tindana P, Ghansah A, MacInnis B, Kwiatkowski D, Djimde AA. 2014. K13-Propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. Journal of Infectious Diseases, 211, 1352–1355. [Google Scholar]
  20. Karl S, Gurarie D, Zimmerman PA, King CH, St Pierre TG, Davis TME. 2011. A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS ONE, 6, e20805. [CrossRef] [PubMed] [Google Scholar]
  21. Kumar N, Zheng H. 1990. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitology Research, 76, 214–218. [CrossRef] [PubMed] [Google Scholar]
  22. Lelièvre J, Almela MJ, Lozano S, Miguel C, Franco V, Leroy D, Herreros E. 2012. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence “transmission blocking” assay. PLoS ONE, 7, e35019. [CrossRef] [PubMed] [Google Scholar]
  23. Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, Toure S, Sanogo K, Dama S, Sidibe B, Kone A, Thera MA, Plowe CV, Doumbo OK, Djimdé AA. 2012. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. American Journal of Tropical Medicine and Hygiene, 87, 23–28. [CrossRef] [Google Scholar]
  24. Maïga Ascofaré O, May J. 2015. Is the A578S single-nucleotide polymorphism in K13-propeller a marker of emerging resistance to artemisinin among Plasmodium falciparum in Africa? Journal of Infectious Diseases, 213, 165–166. [CrossRef] [Google Scholar]
  25. Mehra N, Bhasin VK. 1993. In vitro gametocytocidal activity of artemisinin and its derivatives on Plasmodium falciparum. Japanese Journal of Medical Science and Biology, 46, 37–43. [CrossRef] [Google Scholar]
  26. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. 2008. Artemisinin resistance in Cambodia 1 (ARC1) study consortium. Evidence of artemisinin-resistant malaria in western Cambodia. New England Journal of Medicine, 359, 2619–2620. [CrossRef] [PubMed] [Google Scholar]
  27. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ. 2008. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malaria Journal, 7, 125. [CrossRef] [PubMed] [Google Scholar]
  28. Omumbo JA, Hay SI, Goetz SJ, Snow RW, Rogers DJ. 2002. Updating historical maps of malaria transmission intensity in East Africa using remote sensing. Photogrammetric Engineering and Remote Sensing, 68, 161–166. [PubMed] [Google Scholar]
  29. Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, Coulibaly D, Thera MA, Diallo N, Dara A, Sagara I, Gil JP, Bjorkman A, Takala-Harrison S, Doumbo OK, Plowe CV, Djimde AA. 2015. Polymorphisms in the K13-Propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali. American Journal of Tropical Medicine and Hygiene, 92, 1202–1206. [CrossRef] [Google Scholar]
  30. Piyaphanee W, Krudsood S, Tangpukdee N, Thanachartwet W, Silachamroon U, Phophak N, Duangdee C, Haoharn O, Faithong S, Wilairatana P, Leowattana W, Looareesuwan S. 2006. Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene, 74, 432–435. [Google Scholar]
  31. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ. 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 60, 1019–1023. [Google Scholar]
  32. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ. 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet, 347, 1654–1658. [CrossRef] [PubMed] [Google Scholar]
  33. Proietti C, Pettinato DD, Kanoi BN, Ntege E, Crisanti A, Riley EM, Egwang TG, Drakeley C, Bousema T. 2011. Continuing intense malaria transmission in Northern Uganda. American Journal of Tropical Medicine and Hygiene, 84, 830–837. [CrossRef] [Google Scholar]
  34. Schneider P, Bousema T, Omar S, Gouagna L, Sawa P, Schallig H, Sauerwein R. 2006. Submicroscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. International Journal for Parasitology, 36, 403–408. [CrossRef] [PubMed] [Google Scholar]
  35. Sinden RE. 1982. Gametocytogenesis of Plasmodium falciparum in vitro: an electron microscopic study. Parasitology, 84, 1–11. [CrossRef] [PubMed] [Google Scholar]
  36. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT. 2009. Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs. Acta Tropica, 109, 108–117. [CrossRef] [PubMed] [Google Scholar]
  37. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Nhien NTT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Ariey F, Mercereau-Puijalon O, Menard D, Newton PN, Khanthavong M, Hongvanthong B, Starzengruber P, Fuehrer HP, Swoboda P, Khan WA, Phyo AP, Nyunt MM, Nyunt MH, Brown TS, Adams M, Pepin CS, Bailey J, Tan JC, Ferdig MT, Clark TG, Miotto O, MacInnis B, Kwiatkowski DP, White NJ, Ringwald P, Plowe CV. 2015. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. Journal of Infectious Diseases, 211, 670–679. [CrossRef] [Google Scholar]
  38. Takala-Harrison S, Laufer MK. 2015. Antimalarial drug resistance in Africa: key lessons for the future. Annals of the New York Academy of Sciences, 1342, 62–67. [CrossRef] [PubMed] [Google Scholar]
  39. Talman AM, Domarle O, McKenzie F, Ariey F, Robert V. 2004. Gametocytogenesis: the puberty of Plasmodium falciparum. Malaria Journal, 3, 24. [CrossRef] [PubMed] [Google Scholar]
  40. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P. 2001. Artesunate reduces but does not prevent post-treatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases, 183, 1–6. [CrossRef] [Google Scholar]
  41. Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, Tagbor H, Williams J, Bojang K, Njie F, Desai M, Kariuki S, Gutman J, Mathanga DP, Martensson A, Ngasala B, Conrad MD, Rosenthal PJ, Tshefu AK, Moormann AM, Vulule JM, Doumbo OK, ter Kuile FO, Meshnick SR, Bailey JA, Juliano JJ. 2015. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. Journal of Infectious Diseases, 211, 680–688. [Google Scholar]
  42. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, Lin K, Kyaw MP, Plewes K, Faiz MA, Dhorda M, Cheah PY, Pukrittayakamee S, Ashley EA, Anderson TJC, Nair S, McDew-White M, Flegg JA, Grist EPM, Guerin P, Maude RJ, Smithuis F, Dondorp AM, Day NPJ, Nosten F, White NJ, Woodrow CJ. 2015. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infectious Diseases, 15, 415–421. [CrossRef] [Google Scholar]
  43. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP. 2009. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malaria Journal, 8, 253. [CrossRef] [PubMed] [Google Scholar]
  44. White NJ. 2008. The role of anti-malarial drugs in eliminating malaria. Malaria Journal, 7, S8. [CrossRef] [PubMed] [Google Scholar]
  45. WHO. 2010. Basic Malaria Microscopy-Part I. Learner’s guide. WHO: Geneva. 1991. [Google Scholar]
  46. World Health Organization. 2014. World Malaria Report 2014. WHO: Geneva. [Google Scholar]
  47. World Health Organization. 2015. Guidelines for the treatment of malaria, 3rd edition, 1–318. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.